A one-minute look at managed care news during the week of March 2, 2015, including oral arguments for King v. Burwell and the approval of the first biosimilar in the United States.
The Supreme Court of the United States heard oral arguments for King v. Burwell this week, and at the end of the hearing the justices were clearly divided about the legality of tax subsidies for consumers on the federally facilitated marketplace.
In oncology news, the US now has its first biosimilar with the FDA approval of Sandoz’s Zarxio for some cancer patients, plus the National Cancer Institute’s director is stepping down.
Finally, The American Journal of Managed Care convened a panel of experts to discuss the role of formulary management in the changing dynamics for hepatitis C. Listen to the panel discussion here.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen